skip to main content
Idioma:
Resultados 1 2 3 next page
Mostrar Somente
Refinado por: idioma: Inglês remover Inflammatory Bowel Diseases remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of cyclosporin A on cell adhesion molecules and leukocyte‐endothelial cell interactions in experimental colitis
Effect of cyclosporin A on cell adhesion molecules and leukocyte‐endothelial cell interactions in experimental colitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of cyclosporin A on cell adhesion molecules and leukocyte‐endothelial cell interactions in experimental colitis

Soriano‐Izquierdo, Antonio ; Gironella, Meritxell ; Massaguer, Anna ; Salas, Antonio ; Gil, Félix ; Piqué, Josep M. ; Panés, Julián

Inflammatory bowel diseases, 2004-11, Vol.10 (6), p.789-800 [Periódico revisado por pares]

Philadelphia: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
2
Down‐regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis
Down‐regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Down‐regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis

Seguí, Joaquim ; Gil, Fèlix ; Gironella, Meritxell ; Alvarez, Manuel ; Gimeno, Mercedes ; Coronel, Pilar ; Closa, Daniel ; Piqué, Josep M ; Panés, Julián

Inflammatory bowel diseases, 2005-10, Vol.11 (10), p.872-882 [Periódico revisado por pares]

Philadelphia: Lippincott Williams & Wilkins, Inc

Texto completo disponível

Citações Citado por
3
"IBDCHIP": A New Strategy to Predict Clinical Course and Response to Therapy in Patients With IBD
"IBDCHIP": A New Strategy to Predict Clinical Course and Response to Therapy in Patients With IBD
Material Type:
Artigo 		Adicionar ao Meu Espaço

"IBDCHIP": A New Strategy to Predict Clinical Course and Response to Therapy in Patients With IBD

Sans, M. ; Artieda, M. ; Tejedor, D. ; Cara, C. ; Aceituno, M. ; Alvarez-Lobos, M. ; Yagüe, L. ; Arostegui, L. ; Quintó, L. ; Simón, L. ; Martínez, A. ; Piqué, J. M. ; Panés, J.

Inflammatory bowel diseases, 2006-04, Vol.12, p.S19 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017
Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017

Hanauer, S ; Colombel, J ; Sandborne, W ; Panes, J ; McColm, J ; Schreiber, S

Inflammatory bowel diseases, 2007-05, Vol.13 (supplement), p.647 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results
Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results
Material Type:
Artigo 		Adicionar ao Meu Espaço

Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results

Sandborn, W ; Colombel, J ; Panes, J ; Scholmerich, J ; McColm, J ; Schreiber, S

Inflammatory bowel diseases, 2007-05, Vol.13 (supplement), p.672 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017
Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of certolizumab pegol in patients with prior Influximab use: O-0017

Hanauer, S ; Colombel, J ; Sandborne, W ; Panes, J ; McColm, J ; Schreiber, S

Inflammatory bowel diseases, 2007-05, Vol.13, p.647 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results: P-0080
Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results: P-0080
Material Type:
Artigo 		Adicionar ao Meu Espaço

Certolizumab pegol efficacy is greater with more recent-onset Crohnʼs Disease: PRECiSE 2 results: P-0080

Sandborn, W ; Colombel, J ; Panes, J ; Schölmerich, J ; McColm, J ; Schreiber, S

Inflammatory bowel diseases, 2007-05, Vol.13, p.672 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4): O-028
Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4): O-028
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4): O-028

Schreiber, S ; Panes, J ; Mason, D ; Lichtenstein, G ; Sandborn, W

Inflammatory bowel diseases, 2008-01, Vol.14, p.S8-S9 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4)
Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and tolerability of certolizumab pegol are sustained over 18 months: data from PRECiSE 2 and its extension studies (PRECiSE 3 and 4)

Schreiber, S ; Panes, J ; Mason, D ; Lichtenstein, G ; Sandborn, W

Inflammatory bowel diseases, 2008-02, Vol.14, p.S8-S9 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Health‐related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality
Health‐related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Health‐related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality

Vidal, àngela ; Gómez‐Gil, Esther ; Sans, Miquel ; Portella, Maria J. ; Salamero, Manel ; Piqué, Josep M. ; Panés, Julián

Inflammatory bowel diseases, 2008-07, Vol.14 (7), p.977-983 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (22)
  2. Revistas revisadas por pares (22)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.